3/4/2024 12:09:19 PM - Retreating below its 50 DMA line ($76) with today's 2nd consecutive volume-driven loss. Reported very strong earnings for the Dec '23 quarter versus the year-ago period. Prior quarterly and annual earnings comparisons were not strong and steady, leaving concerns with regard to the fact-based investment system's fundamental guidelines.

8/14/2023 12:20:50 PM - Rebounded above its 50 and 200 DMA lines and it is approaching prior highs with today's 4th consecutive volume-driven gain. Reported very strong earnings increases for the Mar and Jun '23 quarters versus the year-ago periods. Prior quarterly and annual earnings comparisons were not strong and steady, leaving concerns with regard to the fact-based investment system's fundamental guidelines.

8/6/2020 12:26:55 PM - Gapped down today and undercut its 50 DMA line ($80.83) with today's 4th consecutive volume-driven loss. Reported earnings +13% on +5% sales revenues for the Jun '20 quarter, and prior quarterly earnings comparisons were not strong and steady above the +25% minimum guideline (C criteria). Sub par sales revenues growth rate is not a great match with the fact-based investment system's fundamental guidelines.

5/7/2020 12:53:49 PM - Reported earnings +0% on +5% sales revenues for the Mar '20 quarter, and prior quarterly earnings comparisons were not strong and steady above the +25% minimum guideline (C criteria). Sub par sales revenues growth rate is not a great match with the fact-based investment system's fundamental guidelines.

4/21/2020 12:14:53 PM - Reported earnings +0% on +6% sales revenues for the Dec '19 quarter, and prior quarterly earnings comparisons were not strong and steady above the +25% minimum guideline (C criteria). Sub par sales revenues growth rate is not a great match with the fact-based investment system's fundamental guidelines.

3/20/2020 12:45:46 PM - Reported earnings +0% on +6% sales revenues for the Dec '19 quarter, and prior quarterly earnings comparisons were not strong and steady above the +25% minimum guideline (C criteria). Sub par sales revenues growth rate is not a great match with the fact-based investment system's fundamental guidelines.

3/19/2020 12:42:43 PM - Reported earnings +0% on +6% sales revenues for the Dec '19 quarter, and prior quarterly earnings comparisons were not strong and steady above the +25% minimum guideline (C criteria). Sub par sales revenues growth rate is not a great match with the fact-based investment system's fundamental guidelines.

3/9/2020 12:25:11 PM - Reported earnings +0% on +6% sales revenues for the Dec '19 quarter, and prior quarterly earnings comparisons were not strong and steady above the +25% minimum guideline (C criteria). Sub par sales revenues growth rate is not a great match with the fact-based investment system's fundamental guidelines.

8/8/2019 12:25:53 PM - Gapped down today violating its 50 DMA line. Reported earnings +14% on +4% sales revenues for the Jun '19 quarter, breaking a streak of 5 consecutive quarterly earnings comparisons above the +25% minimum guideline (C criteria). Sub par sales revenues growth rate is not a great match with the fact-based investment system's fundamental guidelines.

6/11/2019 12:30:06 PM - Pulling back from a new 52-week high hit on the prior session. Reported earnings +33% on +4% sales revenues for the Mar '19 quarter, its 5th consecutive quarter above the +25% minimum guideline (C criteria). Sub par sales revenues growth rate is not a great match with the fact-based investment system's fundamental guidelines.

4/5/2019 12:32:05 PM - Perched within close striking distance of its 52-week high. Reported earnings +45% on +5% sales revenues for the Dec '18 quarter, its 4th consecutive quarter above the +25% minimum guideline (C criteria). Sub par sales revenues growth rate is not a great match with the fact-based investment system's fundamental guidelines.

11/5/2018 12:22:59 PM - Last noted in the 11/01/18 mid-day report when it gapped up but abruptly reversed below its 50 DMA line, and it has been finding support near its 200 DMA line. Reported earnings +125% on +6% sales revenues for the Sep '18 quarter, its 3rd consecutive quarter above the +25% minimum guideline (C criteria). Sub par sales revenues growth rate is not a great match with the fact-based investment system's fundamental guidelines.

11/1/2018 11:58:02 AM - Gapped up today but abruptly reversed below its 50 and 200 DMA lines. Reported earnings +125% on +6% sales revenues for the Sep '18 quarter, its 3rd consecutive quarter above the +25% minimum guideline (C criteria). Sub par sales revenues growth rate is not a great match with the fact-based investment system's fundamental guidelines.

10/8/2018 12:22:47 PM - Gapped down today and violated its 50 DMA line ($53.71). Last noted with caution in the 9/17/18 mid-day report - "Showed improved earnings increases in the Mar and Jun '18 quarters. Prior sales revenues and earnings history is not a great match with the fact-based investment system's fundamental guidelines."

9/17/2018 12:20:59 PM - Showed improved earnings increases in the Mar and Jun '18 quarters. Prior sales revenues and earnings history is not a great match with the fact-based investment system's fundamental guidelines.